← Back to front page
United States · Platforms & data · TipRanks

Innovent’s Zybrivo Receives Positive CHMP Opinion for First-Line NSCLC Treatment

Published by TipRanks · United States 8 h ago
Innovent’s Zybrivo Receives Positive CHMP Opinion for First-Line NSCLC Treatment
TipRanks

Detailed summary

The latest announcement is out from Innovent Biologics ( (HK:1801) ).

Read the full article on TipRanks Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tipranks.com)

Also worth reading